What did everyone at HIMSS have in COMMON… WELL…THE PATIENT

I am on the plane on my way back to Los Angeles after a week in New Orleans for the HIMSS Conference (www.himssconference.org). It was an extraordinary week for MMRGlobal as one of the “Most Wanted” to see at the show.  In some cases, being most wanted was driven by an interest in understanding what visitors to our booth had read about the Company’s patents and other intellectual property, but mostly because nearly every hospital administrator and Chief Technology Officer had Personal Health Records and interoperability on their shopping list going into Stage 2 of Meaningful Use.

And if it wasn’t a hospital in the booth looking for a PHR, they were a vendor also looking to purchase services to improve patient engagement, or to purchase the companies that provide the services that create patient engagement.  One thing for sure, it was by far our biggest HIMSS yet, and everybody seems to be interested in buying, selling, acquiring or investing in anyone that offers tools for the patient, especially if it involves a PHR.

The week started with the food in New Orleans and ended with one more order of barbeque shrimp.  However, the real focus of the week was anything but the food.  It was about the ONC Coordinator, Dr. Farzad Mostashari, one of the most important men in my world,  who in his keynote speech addressed the ‘human toll’ of a broken healthcare system, and how the way to fix it was though promoting interoperability and increasing transparency and access to data for patients, also known as a Personal Health Record.  He went on to proclaim an agenda of no more excuses about patients not being able to get a copy of their medical records because of HIPAA. All I could hear at that point of his presentation was the theme “Our Day Has Come…” or something like that.

Dr. Mostashari went on, suggesting that to get us there, stimulus monies would go up to fund interoperability and offset any competitive disadvantage from sharing patient data.  It was kind of like watching Kevin Costner in “Field Of Dreams,” when he was told by the “voice,” “If You Build It They Will Come.”  And it looks like ONC will help build it and pay for it.

I have gotten dozens of calls from shareholders asking about the show and I could not have done a better job of telling them what it meant to their company than to explain that the United States government’s agenda of patient engagement is just beginning, and that patient engagement is what MMR is about. And to borrow from the “Music Man,“ with a capital T and that rhymes with P and that stands for PHR.
Then on March 4, the first day of exhibits at the show, patents dominated the headlines, leading to a story entitled Patent Wars Heat Up and Cool Down at #HIMSS13. McKesson Corporation and Epic had announced a settlement of their longstanding, massive patent infringement case. Based on that announcement, the spotlight of the media shined on us and the recent press surrounding MMR’s extensive health IT patent portfolio and its possible relevance to the market. Our patent portfolio includes seven U.S. patents, as well as patents in 12 additional countries of commercial interest issued pending and applied for, including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, South Korea, Israel, and European nations.  The article explains the MMR patents, integrated into our existing products and services which include Personal Health Records, Patient Portals and other Electronic Medical Record systems.

That may explain why, as I sat on the plane with dozens of CIO’s and Administrators from hospitals in California, who were also catching the last non-stop Delta flight out of New Orleans, I felt like I could fly without the jet. It took 8 years of sweat equity and more than $20 million for MMR to get to where it is today. It took both the Bush and Obama Administrations. It took government mandates, $20 billon in stimulus (so far, with more to come), and a massive worldwide push to make patients aware of the importance of joining the movement of managing their personal health.  And then it took the invention of Meaningful Use.

Also on March 4th, at 11 AM, my world got rocked when five of the biggest Health IT vendors, representing an estimated 41% of the entire EMR market, announced the CommonWell™ Health Alliance. For the first time, it was like the day I figured out how prepaid phone cards could sell through mass merchandisers, turning a $5,000 investment into a billion dollar market cap company, before I resigned as CEO.

Cerner, McKesson, Allscripts, athenahealth, Greenway Medical Technologies and RelayHealth announced they were joining together for a single purpose of improving the quality of care delivery while working to lower costs for care providers, patients and the industry as a whole.  The good news, and the validation of 8 long years, is that it starts with MMR’s primary customer, “the patient,” who triggers the ability of achieving data liquidity between systems, based on “Patient Authorizations.”

Nearly every presentation MMR has made over the past several years includes a depiction of how silos in healthcare keep providers from talking to one another. So when John Hammergren, Chairman and CEO, McKesson Corporation, said,  “A national and trusted health information exchange will break down the information silos in health care and should dramatically improve the quality and cost effectiveness of care delivery,” the comment validated my beliefs in MMR and confirmed to me that our focus since inception on inventing and protecting technology surrounding PHRs was to take the right path from the beginning.

Neal Patterson, Co-Founder, Chairman, CEO and President of Cerner Corporation, stated, “Consumers not only have a right to their data, but also have the ability to mobilize it in the pursuit of better health. The Alliance is designed in part to Help providers deliver a history of recent patient care encounters, and, with appropriate authorization, patient data across multiple providers and episodes of care.”

That’s what MMR is all about, we provide Personal Health Records to any patient, anywhere they are in the world, from any healthcare professional, regardless of technology, with or without an EMR, plus a whole lot more. MMR is designed to provide Personal Heath Records from a lifetime of encounters regardless of where they originate or what format they currently appear in.

And the drumbeat went on, with CEOs from Allscripts, athenahealth, Greenway and RelayHealth echoing the fight for the rights of the patient and the betterment of care. http://tinyurl.com/9wmbyee

However, not all were singing the praises of Commonwell. Epic Founder and Chief Executive Officer Judy Faulkner, stated, “We did not know about it. We were not invited.”  Epic Executive Vice President Carl Dvorak, commented, “Despite the claims made by the members of the CommonWell Health Alliance, nobody asked Epic to join the group.”  He continued, “I would really sincerely hope they (meaning CommonWell), put their energy behind true national standards.”

In or out of CommonWell, clearly, Epic is demonstrating they also care about patients and interoperability based on their existing personal health record offerings.

ONC Chief Dr. Mostashari was also asked his thoughts on the Commonwell – Epic controversy surrounding the announcements and comments.  He was quoted as saying, “We have to zoom out a little bit and not get into the he-said she-said. [CommonWell] is incontrovertible evidence that interoperability and exchange is now a key market differentiator and vendors large and small are committed — five years ago that was not true. There is not a vendor in the country that can be blind to the need for interoperability. I welcome any market-based approach.”

The mood at the closing of the show seemed to indicate that most everyone, including the CEOs of Commonwell and Epic agreed that … we all have one thing in common-the patient,  and that the patient has a right to their medical records.

In an industry where agreement and standardization are more than challenging, let’s hope that the CEOs mentioned in this blog can all agree that MMR’s “patient facing” products and services are for the good of all patients.  It’s just one more thing that I am working hard to create agreement on.


Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Tel. 310-476-7002, Fax 206-374-6136
Follow me on Twitter at BobLorschTweets

Tags: , , , , , , , , , , , , , , , ,

This Blog Speaks For Itself

Thank you for your thoughts, friendship & support.

Click the page below for the full story


Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter at BobLorschTweets

Tags: , , , , , , , , , , , , , , , ,

“FreeAfridi.com” Probably One of the Most Important Blogs I Have Ever Written…

Last week, I was in Washington, DC as CEO of MMRGlobal briefing the Congressional Oversight Subcommittee of the House Science, Space, and Technology Committee about my concerns on how eleven billion dollars and counting is being spent under the government’s EHR Incentive Programs.  The monies are being spent in spite of the widely known fact that there is no interoperability and hardly any ability to create a comprehensive online personal health record, two items that were mandated as part of Executive Orders and other requirements to provide electronic medical records and personal health records (PHRs) to Americans by 2014. Of course, by being there I also hoped to have the opportunity to draw attention to the fact that MyMedicalRecords is already delivering interoperability and a comprehensive PHR now….today.

During my visit, I was asked by Congressman Dana Rohrabacher to lend my marketing expertise to help raise awareness to the plight of Dr. Afridi.  My first question was, “Who is Dr. Afridi?”  Then I quickly learned what I did not know, that Dr. Shakil Afridi is the man who pinpointed the location of Osama bin Laden for the United States.  Without Dr. Afridi, the United States may not have found Osama bin Laden.  His reward was to be abandoned and left behind in a Pakistan prison, reportedly being regularly tortured, and sentenced to live side-by-side with the militants who continue killing our American soldiers.  I was shocked and I knew that something had to be done. I never thought that America would leave a hero behind.

The following is a copy of a news release that is being issued from MMRGlobal today.  It explains in greater detail what I did in Washington and how those meetings led to Kira and me calling on Oscar® to help FREE AFRIDI.

If you believe, like Kira and I do, that this man deserves our combined voice to be released and regain his freedom, then visit www.freeafridi.com, read the Letter from Congressman Rohrabacher, and do what you can to help bring this great American hero to where he belongs in America. Kira and I will be doing our part on The Red Carpet events throughout the weekend and on news broadcasts wherever we can similar to the one on CBS that is here: http://losangeles.cbslocal.com/2013/02/20/can-zero-dark-thirty-oscars-help-free-imprisoned-doctor-who-helped-find-bin-laden.



MMRGlobal CEO Briefs Congressional Oversight Subcommittee on Questions Surrounding Better Ways to Have Spent $11 Billion on HIT Incentives

Los Angeles, CA (February 22, 2013) – Robert H. Lorsch, Chairman and CEO of MMRGlobal, Inc. (OTCQB: MMRF) (“MMR”), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals, recently met with U.S. Congressional Representatives along with their staffs and the staff of the Subcommittee on Oversight of the House Committee on Science, Space, and Technology.  The purpose of the meeting was to brief Representatives and staff on an independent compilation of articles, blogs, reports and opinions pertaining to questions surrounding the payments of nearly $11 billion in stimulus monies under the government’s EHR and Meaningful Use incentive programs.  The meeting was also intended to address concerns that primary requirements set forth in federal legislation pertaining to the provisioning of Electronic Health Records (EHRs) were not being met, specifically those which pertain to standardization, interoperability and requirements that most Americans have access to all their protected personal health information through some type of secure Personal Health Record similar to existing offerings from MMR.

According to Lorsch, “After the briefing portion of my presentation, I was able to demonstrate to staff  the MyMedicalRecords Personal Health Record and explain how it could be deployed to everyone in America at an annual cost that would be less than the cost of one EMR system in a large hospital.  At that time, I had no idea that the points raised in my presentation would become Page One of The New York Times the following Wednesday, less than one week later.” (http://www.nytimes.com/2013/02/20/business/a-digital-shift-on-health-data-swells-profits.html?_r=0)

While in Washington, Lorsch was also asked to attend a meeting with Representative Dana Rohrabacher regarding the plight of Dr. Shakil Afridi, the Pakistani physician that verified Osama bin Laden’s location for the United States. Today, Dr. Afridi is in a Pakistan prison sentenced to 33 years, abandoned, and reportedly being tortured.  As a result of that meeting, Lorsch began a campaign, launched in a Special Oscars® issue of The Hollywood Reporter today, and at www.FreeAfridi.com. The campaign appeals for the release of Dr. Afridi by asking that the celebrities attending the Oscars® share a moment of their limelight to help draw attention to America’s abandoned hero.

“After making numerous presentations on behalf of MyMedicalRecords, where I requested support for PHRs, this was the first time that I left Washington believing that the value of a cost-effective, patient-controlled Personal Health Record was being embraced.  That includes previous meetings and presentations to former HHS Secretary Mike Leavitt and Homeland Security Secretary Tom Ridge, as well as Congressional Representatives including senior staff members in the office of The Honorable Ted Kennedy, as well as ONC staff and National Coordinators for Health IT David J. Brailer, M.D. and David Blumenthal, M.D.,” Lorsch added.

The briefing also emphasized the point that without standardization, the current HIT infrastructure did not allow a level playing field for small businesses competing with larger health IT equipment and system providers who dominate more than two-thirds of the marketplace. Information included in the briefing also covered how contractual terms from larger EMR systems are written to discourage hospitals from using other vendors which is counter to requirements of standardization and interoperability.

MMR’s technology specifically addresses the issues of interoperability while provisioning a comprehensive Personal Health Record to the patient.  The Company offers solutions for patients, physicians and hospitals that seamlessly connect along the lines of the government’s stated goal of interoperability and  empowering patients, providing access to their health information in a PHR. MMRGlobal also has an extensive healthcare IT patent portfolio, which includes seven U.S. patents: Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240.  The MMR Patent Portfolio includes nearly 400 claims as well as additional applications and continuation applications.  The patents involve inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems.  MMR also has been granted patents and has other pending applications in countries of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, South Korea, Israel, and European nations.

Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor,  Los Angeles, CA 90010, Tel. 310-476-7002

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation,  intellectual property enforcement actions, infringement claims or litigation, intellectual property licenses, and future performance, management’s expectations, beliefs, intentions, estimates or projections, constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “potential,” “intend,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, sources, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company’s health IT and biotechnology intellectual property assets in the U.S. and internationally;  the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company’s products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market’s acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company’s filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Tags: , , , , , , , , , , , , , , , , ,

In Order to Keep Life Exciting, You Must Take a Few Risks to Reap the Rewards

Being CEO of a company is anything but boring.  Who would have thought that each $2,000 invested as founders’ capital into a publicly traded company which I co-founded and ran, would someday be worth ten million dollars in only three years, as it did.  It proves the adage that good things are worth waiting for, and it looks like a similar story awaits at MMRGlobal.  Who would have thought that MMR would evolve into a Company owning a portfolio of Health IT and Biotech assets valued at as much as a billion dollars, not including the value of patents in twelve additional countries http://michaelbass.com/PDF/Patent_Valuation.pdf .

For those who have been there and supported the Company since the beginning in 2005, thank you.  As we head into the 2013 Super Bowl weekend the one thing not to bet against is the future of Health IT and MMR’s role in it.

What keeps my life exciting is that MyMedicalRecords has only just begun. That’s because the Meaningful Use requirements that mandate patients receive online access to their Personal Health Information takes effect in 2014.

MMR is a company that took a big risk fostering ideas that were hatched before their time.  And there are advantages to being the early first mover.  We benefited with great inventions that resulted in 7 US patents, plus continuation patents and pending patents, and more patents in countries around the world, with nearly 400 U.S claims, and hundreds more internationally.  In fact, MMR has additional patents issued, pending and applied for in Australia, New Zealand, Singapore, Mexico, Canada, Europe, Israel, Japan and South Korea. If MMR were in a Master Charge commercial, its intellectual property would be described as PRICELESS!

Working with legal counsel, we have spent the past year pursuing license agreements and strategic relationships for the use of MMR’s Health IT patents and other Intellectual Property.  The industry is recognizing the value of our IP and the Company has already entered into licensing and strategic business relationships.

We believe our patents increase the bar, making it difficult for hospitals, physician groups, healthcare professionals and vendors of  Personal Health Records and patient portals to sell their products and services without infringing on MMR’s IP.

And while MMR owns a significant portfolio of health information technology IP, the Company also owns biotech assets, samples and patents created at a cost of more than $100 million and which are already the subject of a $13 million license agreement with a major biotech company.

Meanwhile, the next 30 days promise to be one of the most exciting periods in MMR’s history.  On February 10th I am scheduled to attend a series of major customer meetings in Pennsylvania and MMR is hosting a dinner for carriers and payers representing more than 100 million lives.

On the 11th and 12th I attend meetings in Washington DC with representatives from Congress to discuss the use and effectiveness of more than $10 billion in paid out stimulus monies and other opportunities to improve care and reduce costs in preparation for future hearings. While there, I also plan on meeting with affinity groups representing seniors, emergency preparedness and other existing association clients of MMR.

Then, it’s two days in New York, where the Company will be telling its story to institutional investors and entertainment conglomerates interested in incorporating interactive health with broadcast and online programming.

Then back to Los Angeles to prepare for HIMSS 2013, which starts March 3rd in New Orleans to more than 40,000 projected attendees and is featuring a keynote address by President Clinton http://www.himssconference.org/.  I am proud to be part of a company that participates in the future of healthcare today.  Although it’s too late to bet on the Super Bowl, it’s not too late to bet on the Future of Health IT.


Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter @BobLorschTweets

Tags: , , , , , , , , , , , ,

Being In The Right Place At The Right Time

Last Friday, my wife Kira went to sleep with a “headache.”  At first I thought she was upset that I was 3 hours late for dinner after a late night of packing my office for my multi-mile marathon walks through the 2013 Consumer Electronics Show in Las Vegas.  However, it did not take long to figure out she really had a headache and the flu. Then the next morning, when I woke up with fever, unable to move more than 10 feet from the bathroom, I knew that we were both bit by the bug.

In any event, with all the strength I could muster, I decided that I should still prepare for CES on Monday in case a miracle cured me and I could still go to the big show.  So ritualistically, as I do on Saturdays, I went for a haircut.  Not that I have a lot to cut – it’s just that when you have as little hair as I do it deserves the very best.  So off I went, barely able to hold my head straight in Koby’s chair.

During my haircut, I began to reminisce about nearly 40 years of working the CES show for advertising and sales promotion clients, as well as my own companies.  I thought about all the nights in the Las Vegas hospitality suites and the girls, The Knobs Knowledgeable Knob Knowers program I created for stereo maker Wintec, and the girls. I remembered the 50’s Diners with the singing dancing waitresses that I built using Hollywood’s best Back To The Future sets to showcase telecommunications and decorator phone clients – and the girls. My taste buds also reminisced about the gourmet meals in The Bacchanal Room at Caesars Palace, where the girls peeled grapes and fed them sensuously to diners, the millions of Wuppees I sold as show giveaways to stick on the girls and the most successful trade show program of my career, in the 1985 COMDEX convention, where my sales promotion agency, Lorsch Creative Network, was hired by Microsoft, based on my legendary successes at CES …. and of course as my wife will not let me forget – the girls.

That last one is easiest to remember.   As described in the book written by Jennifer Edstrom and Marlin Eller,  Barbarians Led By Bill Gates, as a “marketing mastermind,” in 1983 I got the call from Rowland Hanson, Microsoft VP Marketing, who said, Microsoft wants to own Las Vegas and own the COMDEX show when we launch Windows.  I said “What’s a Microsoft?”  He explained he was launching this software thing called Windows 1.0 and wanted everyone in town for COMDEX to know that the “Windows” were opening BIG. COMDEX was the equivalent of CES for the fledgling computer industry at that time.

In any event, as the book says, when people arrived in Vegas they were awestruck. There was not a taxi in town without Windows signage. The Wuppies were redesigned from having antenna to sporting mouse ears to celebrate the introduction of the “Mouse,” while I personally went from hotel bell stand to bell stand tipping housekeeping to change 20,000 pillow cases (at that time there were only 20,000 rooms) to a pillowcase with a Windows Lullaby silkscreened on the cases.

And as the final Coupe de Gras, we closed as big as we opened after hosting the first trade show concert featuring Glen Campbell in a free Rhinestone Cowboy (boots and all) show for attendees, celebrating in Las Vegas for COMDEX.  Campbell stayed for the entire soiree and standing next to the world’s soon to be most famous computer geek, he said…”I just wanted to welcome y’all here for the Microsoft party and I want you to know this is my good buddy, Bill Gates.”

The crowd exploded, dancing and laughing all night, but the party and the show were no joke. In an initial survey of COMDEX attendees arriving in Las Vegas, 10% of those polled hadn’t even heard of Microsoft. When Hanson’s team conducted an exit poll, the public perception of Microsoft had grown to 90% in one week. It’s amazing what you can do when you are willing to take some risk and think out of the box.  Of course it helps to have an unlimited budget.

Then, four years ago, when I thought my CES days were over, I heard about healthcare emerging in CES.  I went to check out the exhibits in the show referred to as Consumer Connected Health. In the last four years, that group of exhibitors has grown from a handful of booths to an entire pavilion of consumer health electronic products and companion services, with what appears to be hundreds of booths showing something to do with health and fitness.

And despite my flu, thinking only 110% of the public company shareholders of MMRF, I slogged the 2 miles (4 round trip) from the Las Vegas Hotel lobby through the Convention Center to walk the show with the other 150,000 attendees. For the second year in a row, MMRGlobal exhibited in the show as part of the Alcatel- Lucent and ngConnect Connected Health booth next to all the biggies, Verizon, Qualcomm and a ton of other huge players with booths the size of Lorschland.

MMR is on the verge of becoming part of healthcare and my CES history, launching a collection of Wellness & Health IT at work packages to improve the quality of lives. The Company was part of a complete, automated, connected health demonstration, featuring MMR’s Patented MyMedicalRecords.com Personal Health Record. The demonstration showed how MMR connects patients and their doctors in ways that would have been unimaginable only a few years ago.

It was all about Being In The Right Place At The Right Time.  I had so much adrenaline pumping in my veins, my flu bug got squashed. I walked miles through the convention center and talked to all the companies relevant to MMR’s PHR products and services. I did demonstrations, I shared the news about the company’s patents and intellectual property, I attended meetings where we discussed how to integrate with everything, including the HAPIfork.

I shook hands (using my Purell Sanitizer, of course) and met dozens of new health players, arranging follow-ups (at their request) to work together in 2013.  I also continued my networking with the giants, including Verizon & Qualcomm, where we have been working on formalizing strategic relationships for years.  Clearly, 2013 is not only the year of the Snake, it’s the year of eHealth and Health IT.

After a less than two-day whirlwind show, I was thankful that I went for a haircut, or I would have never reminisced and remembered how important it is to be in the Right Place at The Right Time.

Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter at BobLorschTweets

Tags: , , , , , , , , , , , ,

We All Learned Some Things In 2012 We Can Remember As We Move Forward Into 2013.

Shortly before the end of 2011 I published a Blog entitled “Perspective, Use It Or Lose It,” you can read it at http://blog.mmrglobal.com/2011/12/. It talks about my belief system of how moving one foot in front of the other gets you to the finish line when you enjoy the journey, not the destination.

Although it’s only been a little more than a year since we were awarded our first two U.S. health IT patents, I had no idea that we would end 2012 with a total of five and with over 300 claims protecting the intellectual property covering features and benefits of our MyMedicalRecords.com Personal Health Record. At the same time, our patent prosecution efforts continued in 12 additional countries and we began to launch our PHR’s in China.

While the Company continued to receive more patents in health IT, it became clear that they could be relevant to any healthcare professional that plans on meeting Stage 2 Meaningful Use requirements. According to the U.S. government, starting in 2014, all Americans are to be given timely access to a PHR.

As I look back on 2012, we started the year focusing on our plan to continue selling PHR’s direct to consumers, employers and associations. Throughout the year, we began the process of integrating numerous programs to seniors, emergency clinics, animal lovers, benefit and affinity groups and other early stage telemedicine providers. Then in January, we also started approaching mass marketers and pharmacy chains, offering a Prepaid Personal Health Record Card at retail. We launched it at the 2012 Consumer Electronics Show in Las Vegas.

At CES we also showcased our MyMedicalRecords.com service, as a telemedicine portal in the ng Connect booth. Ng Connect is a consortium of leading-edge technology companies sponsored by Alcatel-Lucent. Through the ng Connect program, MMR has begun interacting with companies around the world interested in providing our PHR as the last mile to their local 4G telemedicine solutions like the Alcatel Lucent Connected Medicine Initiative at http://connectedmed.com/. Next week, we will again join ng Connect and Alcatel-Lucent for a second consecutive year at CES, demonstrating MyMedicalRecords.com as a connected telemedicine portal.

On the biotech side, MMR received two additional patents for our anti-CD20 antibodies and B-Cell vaccine in Mexico. We also received a patent in Mexico for our Personal Health Record health IT service offerings. As a result of the Company’s intellectual property portfolio, we have already received more than one million dollars in license fees and signed numerous biotech and health IT licensing agreements which already call for payments in excess of 40 million dollars over the next four years.

In early February, Spalding Surgery Center of Beverly Hills began going paperless using MMRPro. This was a big deal for them and for us because it proved that MMRPro, our signature document management and scanning solution, had a place in hospitals, group practices and surgery centers. Having installed MMRPro systems nationwide, the Company ended 2012 with a pipeline of more than 17 million dollars’ worth of MMRPro system sales being delivered over the next three years.
When you look at the public markets last year, we have never seen a time when there is so much evidence of the value of patents. In 2013 my priority will be a focus on leveraging that value by expanding the number of organizations that license our patents and other IP.

MMR already has EMR and PHR licensees connected to more than 35,000 physicians. We have spent the last six months sending notices and making presentations to organizations representing more than 1,000 hospitals and hundreds of other types of healthcare professionals in an effort to create licensing opportunities.

In 2013, the Company plans on expanding its list of licensees to include PHR providers, hospitals, surgery centers, veterinarians, universities, nursing organizations, senior care providers, drug manufacturers, governments, radiologists, dentists, wellness providers, retailers, chiropractors and group practices. The Company also intends on identifying its licensing opportunities beyond the U.S., Australia and China to make our way into the many other international markets where the Company holds patents and that are dealing with the modernization of their healthcare system.

I look forward to 2013 being the year in which all those who have supported MMR by sweat equity or financially will see rewards by being in the right place at the right time “The Future of Healthcare Today.”

As the headline says, we all learned something in 2012 and I will use the “life training” in 2013. Happy New Year!

Robert H. “Bob” Lorsch, CEO, MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter at BobLorschTweets

How Valuable Can Patent Rights Really Be?

In August of this year, two separate billion dollar verdicts for patent infringement were handed down.  Apple was awarded $1.05 billion in a patent infringement suit against Samsung related to the iPhone and Monsanto was awarded $1 billion in a patent infringement lawsuit against DuPont related to genetically engineered agricultural seed.

One of the questions being debated in the legal community and the media is whether a patent portfolio can have a billion dollar value.  Most experts believe the answer is yes based on the way patent damages are calculated.

Patent damages are compensatory and meant to remedy the loss due to infringement.  There are two ways that patent infringement damages may be calculated monetarily.  The first by awarding a hypothetical reasonable royalty and the second through the calculation of lost profits.  Under either of these approaches the idea is to compensate the patent holder by placing them in the position they would have been in if an infringement had never occurred.

Over the past year, MMRGlobal’s subsidiary, MyMedicalRecords, Inc., has been awarded five patents by the United States Patent and Trademark Office, U.S. Patent Nos. 8,121,855; 8,117,646; 8,117,045; 8,301,466 and 8,321,240, with similar patents issued and/or pending in twelve other countries.  In addition, MMR has hundreds of pending claims involving Personal Health Records and features included in Electronic Medical Records systems in the U.S.

Although reasonable royalty calculations look to industry standard rates for the technology, in most cases there is no industry standard.  As a result, courts often turn to a “hypothetical negotiation” to determine an amount a patent owner would have received if it had licensed the patent to the infringer in an arm’s length licensing relationship.  With health IT projected to be a hundred billion dollar industry fueled by tens of billions in incentives that “hypothetical negotiation” could result in a big number.

The lost profit damage calculation is not so hypothetical.  Instead, it is an approximation of the profits that the patent owner lost due to the presence of the infringer’s product(s) in the marketplace.  This is essentially based on lost sales that the patent holder would have had if no infringing products were on the market.  The lost profits calculation can include what is called the “entire market value rule.”  This rule permits the patent owner to include as lost revenue separate non-patented components that are typically sold along with the patented product.  If that were applied to MMR’s patents, that could be a really big number based on a really big market.

In order to make a belief into a reality, we need to keep thinking out of the “BOX” while placing one foot in front of the other regardless of the obstacles that appear in the way. Then one day we find ourselves ringing the bell on the New York Stock Exchange and the answer to how to do it appears in front of us.  When I started MMR in 2005 I believed it could be the most successful venture of my life. At that time, I did not know how I would get there because there is never certainty in something that has not happened yet.  Through the inner voice of natural knowing I simply knew I could. So I started thinking out of the “BOXES” which became the four corners of many pieces of paper called patent applications.  Now it appears the resultant patents (and pending applications) should help get us through to the most successful venture of my life.

Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter at BobLorschTweets
Edited from an article by Jonathan L. Kennedy of McKee, Voorhees & Sease







Tags: , ,

Don’t Get “Patent Disease Syndrome”

There appears to be a disease going around called Patent Disease Syndrome (“PDS”).  It starts with a little round fur ball (also known as a “Wuppee”) which can either bring a smile to your face or confusion from the bombardment of billion-dollar infringement claims reported in the media (see picture of bug shot under microscope in a laboratory not too far away).

“Do Not Get Bitten By the Patent Disease Syndrome Bug”
Some Things You May Want to Know About the MMRGlobal Patent Portfolio and Did Not Know Who to Ask,” which appears below. MMR owns its products and services and relies on its IP to remain competitive in the marketplace.
As the Company’s CEO and the inventor of our patents, I am proud that we own a portfolio of five issued United States patents with hundreds of claims, as well as other similar health IT patents in at least 12 countries around the world. I also discussed what MMR’s Patent portfolio could mean to the health IT industry and our strategy of working to create strategic business partnerships by selling our products and services or enter into reasonable licensing agreements.

Our strategy is to enable patients to get the benefits of our untethered products so that they can access their personal health information wherever they are anywhere in the world.

In the weeks since that last Blog, Apple has won a billion dollars in a patent suit and now it looks like they may have to pay a chunk to someone else who appears to have won a patent suit from them. Every day, patent claims seem to dominate the headlines of business and trade press. Rather than thinking about hiding in the wake of all the patent IP wars, this Blog is intended to provide relief from what I call the Patent Disease Syndrome (“PDS”).

Patent Disease Syndrome is a very costly and time-consuming disease that can attack when least expected. A few simple preventative steps can protect you from ever having to deal with it.  First, preform an Intellectual Property Audit to protect your IP and protect you from infringing on anyone else’s. Then talk to an MMR patent specialist about why you should purchase or license MMR’s products and services or IP. MMR can help satisfy your quest for your share of the billion-dollar stimulus pie available to you by meeting Meaningful Use Stage 2 requirements. You’ll even find out how much money you can add with the MMR Stimulus program.

As we do in our everyday life, we insure our risks.  Licensing patents is nothing more than paying for the annual software license to prevent your system from getting a virus.  Patents are becoming an important factor in purchasing decisions pertaining to Health IT. Having licenses upfront before the bug bites may be one of the smartest things a hospital or healthcare professional can do and could be a lot cheaper than litigating over them in the future.

So don’t get bitten by the Patent Disease Syndrome bug.  Simply put, patents give patent holders the right to exclude others from using intellectual property that may be part of a product or service you use.  Clearly, in an industry the size of Health IT, that is going to happen. Being aware of risks associated with patent infringement is smart business.

If you would like your own limited edition canister, as shown above, designed by world-famous artist Charles Bragg, filled with Patent Disease Syndrome Bugs, contact investor relations at the email address below and we will send it along.

For specific information about the Company’s patents, which include U.S. Patent Nos. 8,121,855, 8,117,646, 8,117,045, 8,301,466 and 8,321,240, contact Ted Ward at Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP, (Tel. 310-500-3384 / TWard@LinerLaw.com) or me at the contact information that appears below.

 Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010, Tel. 310-476-7002


Some Things You May Want to Know About the MMRGlobal Patent Portfolio and Did Not Know Who to Ask

This Blog is intended to provide information regarding MMR’s patents and its willingness to license hospitals, healthcare providers and their vendors to facilitate the use of technology which may be necessary to satisfy the Health Insurance Portability and Accountability Act (“HIPAA”) and the Health Information Technology for Economic and Clinical Health Act (“HITECH”), and to meet the meaningful use requirement.

MMR is the owner and the Company’s CEO Bob Lorsch is the inventor of five currently issued United States patents and others in at least 12 countries around the world. The patents are related, in general, to the provisioning of Personal Health Records and Electronic Health Records; U.S Patent Nos. 8,121,855, 8,117,646, 8,117,045, 8,301,466 and 8,321,240.  MMR also has numerous additional patent applications pending related to patient information and Personal Health Records (collectively, “MMR’s IP”).  The Company believes that HIPAA, HITECH and other laws related to the healthcare industry, make MMR’s IP relevant to many hospitals and provider plans for the future of healthcare.

The MMR IP discloses a broad range of methods to maintain, communicate, standardize, and manage patients’ health information, such as through a patient portal by way of example.  No different than hundreds of companies that provide other products or services in healthcare and own patents (for example patents related to imaging devices, CT scans or even medical instrument designs), MMR is not attempting to preclude healthcare providers from communicating healthcare records to patients but instead is making available its solution(s) for sale or, in the alternative, seeking a reasonable royalty from entities using another solution that infringes MMR’s IP.

While MMR does own significant patents related to Personal Health Records, it is not a patent “troll.”  MMR is a practicing entity, a company that has itself developed and sells products and services using the MMR patented technology.  For example, MMR’s consumer products include the MyMedicalRecords Personal Health Record.  These products allow documents, images and voicemail messages to be transmitted in and out of the system using a variety of methods, including fax, voice, file upload, email and other forms of messaging and do not rely on any specific Electronic Medical Record (EMR) system to populate an account.  MMR’s professional offerings, MMRPro, provide physician practices and hospitals a cost-effective, end-to-end solution to the expensive and time-consuming process of digitizing paper-based medical records.  Incorporated into the MMRPro system is an integrated patient portal to provide patients with timely online access to their personal health information.  MMR created the tools to connect any patient with any physician or hospital or other healthcare professional anywhere in the world and patented its technology.  MMR understands that there are questions regarding MMR’s IP.  To that extent the Company encourages contacting Mr. Ted Ward at Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP, 310-500-3384, TWard@LinerLaw.com or me at the contact information that appears below.

Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010, Tel. 310-476-7002


The race is on, or rather, the races are on.  Wednesday night was the first debate in the presidential race while another race is on for what service will manage your family’s medical records for you?  And that’s without considering governmental requirements regarding the providing of Personal Health Records (PHRs) by 2014 to you.

The post-debate reality is that Health IT particularly the use of THE Personal Health Record is here to stay.  Both presidential candidates made the case that sharing medical records online between physician work groups at The Cleveland Clinic, Mayo Clinic and others have unequivocally demonstrated how coordination of care with online patient records (including Personal Health Records) can substantially reduce medical costs by reducing duplicate testing, nasty and costly drug interactions, shorter hospital stays while all contributing to better patient outcomes.

Using PHRs and expanding coordination of care to include the patient is projected to provide even better results.  In fact, some say a Personal Health Record on hospital discharges can help reduce readmissions by as much as forty percent.

 So if you have not already jumped on the PHR bandwagon and started one for your family, now is a perfect time to get started as we approach the holiday season when families are together.  It’s a great opportunity to collect all your family’s important health information, doctor’s notes, advance directives, health history, medications and allergies, in one central place in case of an emergency or another unfortunate disaster.

Now I may be biased towards having a www.MyMedicalRecords.com  PHR which will take you about 5 minutes to get started. So if you decide to give it a try you can call the office at 888-808-4667 and Customer Service will help you, or you can try our new www.MMRPersonalTouch.com page where we get your account started for you and collect records for the first family member at no additional cost.  So join the movement towards having a family PHR before a medical emergency or disaster strikes.

Robert H. “Bob” Lorsch,  CEO,  MMRGlobal
Follow me on Twitter at BobLorschTweets